{"id":600,"date":"2021-12-08T22:06:25","date_gmt":"2021-12-08T22:06:25","guid":{"rendered":"https:\/\/medicalmarijuanainc.com\/?p=1013282"},"modified":"2021-12-08T22:06:25","modified_gmt":"2021-12-08T22:06:25","slug":"medical-marijuana-inc-subsidiary-kannaway-announces-november-2021-as-the-best-month-in-company-history-for-japan-division","status":"publish","type":"post","link":"https:\/\/medicalmarijuanainc.com\/2021\/12\/08\/medical-marijuana-inc-subsidiary-kannaway-announces-november-2021-as-the-best-month-in-company-history-for-japan-division\/","title":{"rendered":"Medical Marijuana, Inc. Subsidiary Kannaway\u00ae Announces November 2021 as the Best Month in Company History for Japan Division"},"content":{"rendered":"
SAN DIEGO, Dec. 08, 2021 (GLOBE NEWSWIRE) — via\u00a0NewMediaWire<\/u><\/a>\u00a0—\u00a0Medical Marijuana, Inc.<\/a>\u00a0(OTC: MJNA) (the \u201cCompany\u201d), the first-ever publicly traded cannabis company in the United States that launched the world\u2019s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today that its subsidiary\u00a0Kannaway\u00ae Japan<\/a>\u00a0had its best revenue month in the Company\u2019s history in November 2021.<\/p>\n \u201cWe\u2019ve experienced tremendous growth and success in Japan this quarter,\u201d said Kannaway\u00ae CEO Blake Schroeder. \u201cWe are excited about our continued development throughout Asia-Pacific as we continue to expand our presence throughout the region.\u201d<\/p>\n According to Research and Markets, the global cannabidiol (CBD) oil market is expected to reach\u00a0$5.3 billion by 2025<\/a>\u00a0with Asia-Pacific as one of the fastest-growing regions.<\/p>\n \u201cThe popularity of CBD products in Japan is growing rapidly and we have been able to help further this trend by connecting with consumers to help them become educated on what CBD is and what high-quality CBD products are best for them,\u201d said Kannaway\u00ae Global Sales Officer Peter Dale. \u201cWe are proud to be the market leaders in the CBD category in Japan and around the world.\u201d<\/p>\n To learn more about Kannaway\u00ae, please visit the Company online at\u00a0https:\/\/www.kannaway.com\/<\/u><\/a>.<\/p>\n About Kannaway\u00ae About Medical Marijuana, Inc. Medical Marijuana, Inc.’s headquarters is in\u00a0San Diego, California, and additional information is available at\u00a0OTCMarkets.com<\/a>\u00a0or by visiting\u00a0www.medicalmarijuanainc.com<\/a>. To see Medical Marijuana, Inc.’s corporate video,\u00a0click here<\/a>.<\/p>\n
\n<\/b>Kannaway\u00ae<\/a>\u00a0is a network sales and marketing company specializing in the sales and marketing of hemp-based botanical products. Kannaway\u00ae currently hosts weekly online sales meetings and conferences across the United States, offering unique insight and opportunity to sales professionals who are desirous of becoming successful leaders in the sale and marketing of hemp-based botanical products.<\/p>\n
\n<\/b>We are a company of firsts\u00ae<\/a>. Medical Marijuana, Inc. (MJNA<\/a>) is a cannabis company with three distinct business units in the non-psychoactive cannabinoid space: a global portfolio of cannabinoid-based nutraceutical brands led by\u00a0Kannaway\u00ae<\/a>\u00a0and\u00a0HempMeds\u00ae<\/a>; a pioneer in sourcing the highest-quality legal non-psychoactive cannabis products derived from industrial hemp; and a cannabinoid-based clinical research and botanical drug development sector led by its pharmaceutical investment companies and partners including\u00a0AXIM\u00ae Biotechnologies, Inc<\/a>.<\/a>\u00a0and\u00a0Kannalife, Inc<\/a>. Medical Marijuana, Inc. was named a top CBD producer by\u00a0CNBC<\/a>. Medical Marijuana, Inc. was also the first company to receive historic import permits for CBD products from the governments of\u00a0Brazil,\u00a0Mexico,\u00a0Argentina, and\u00a0Paraguay\u00a0and is a leader in the development of international markets. The company’s flagship product\u00a0Real Scientific Hemp Oil<\/a>\u00a0has been used in several successful clinical studies throughout\u00a0Mexico\u00a0and\u00a0Brazil\u00a0to understand its safety and efficacy.<\/p>\n